Showing results (1311-1320 of 2,755) with videos related to

Sort By:
Pageof 276
Pharmacogenomics|July 9, 2020
miR-365a-5p suppresses gefitinib resistance in non-small-cell lung cancer through targeting PELI3Fannian Li, Haitao Li, Shuai Li, et al.
Pharmacogenomics|November 15, 2012
Influence of the CYP2C9*3 allele on the pharmacological interaction between warfarin and simvastatinMariana Rodrigues Botton, Mara Helena Hutz, Guilherme Suarez-Kurtz
Pharmacogenomics|November 15, 2012
Genetic polymorphisms and novel allelic variants of CYP2C19 in the Chinese Han populationLi-Ming Hu, Da-Peng Dai, Guo-Xin Hu, et al.
Pharmacogenomics|November 15, 2012
miRNA pharmacogenomics: the new frontier for personalized medicine in cancer?Eva Dreussi, Paola Biason, Giuseppe Toffoli, et al.
Pharmacogenomics|November 15, 2012
Building bridges to the future of medicine: recommendations for boosting development of novel and companion diagnosticsJames Creeden
Pharmacogenomics|August 16, 2022
HLA pharmacogenetic markers of drug hypersensitivity from the perspective of the populations of the Greater Middle EastHend Chaker Masmoudi, Nariman Afify, Halima Alnaqbi, et al.
Pharmacogenomics|February 2, 2023
Contrasting ABCB1 pharmacogenetics and psychotropic responses in child and adolescent psychiatry: a case comparisonPragya Kalla, Lisa B Namerow, Sophia A Walker, et al.
Pharmacogenomics|June 6, 2020
ACE2 and COVID-19: using antihypertensive medications and pharmacogenetic considerationsEric M Snyder, Bruce D Johnson
Pharmacogenomics|September 10, 2021
Effects of genetic and nongenetic factors on hyperuricemia in Chinese patients with coronary artery diseaseWeixia Zhang, Yiwen Jin, Juan Li, et al.
Pharmacogenomics|May 26, 2021
Evolution and functional divergence of the ERBB receptor familyShanshan Wu, Jeffrey Haltom, Wenyi Zhao, et al.
Pageof 276